Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Blockchain Solutions Provider Pivots to Psychedelics and a Clear Path to Revenue

Dave Jackson Dave Jackson, Stockhouse
0 Comments| February 7, 2020

{{labelSign}}  Favorites
{{errorMessage}}

The cannabis space has seen its share of troubles over the past 12 months – share prices, down CEO’s shown the door, and general shareholder discontent. Yet, industry analysts believe the sector is still strong with an expected rebound in 2020 after last year’s market correction. But what savvy retail and institutional investors are pivoting to is something that may hold even greater promise over the long-term… psychedelics.

Graph Blockchain Inc. (CSE.GBLC, REGRF, Forum) is a blockchain solutions provider focused on creating best-in-class enterprise application software solutions with a focus on Distributed Ledger Technology, commonly referred to as DLT or Blockchain. This innovative, well-positioned company is on the cutting-edge of global blockchain technology in the agricultural, tech, and cannabis markets. Now, the company is taking its scalable technology to the nascent psychedelic / psilocybin mushroom space.


Why Magic Mushrooms?

Researchers at world-renowned Johns Hopkins University have advocated for the use of magic mushrooms in mental health treatments and for the federal government to reschedule the drug. Early research has indicated that giving patients drugs based on the naturally-occurring active ingredient psilocybin, known for its hallucinogenic properties, could help reboot the brains of people who suffer from mental illnesses like as depression and who are otherwise resistant to treatment. And for the first time, the U.S. Food and Drug Administration (FDA) fast-tracked research on psilocybin from U.K.-based Compass Pathways. In October 2018, Compass’s psilocybin received “breakthrough therapy designation” from the FDA, meaning the study will be hastened through the drug development process. The move could open the door for the clinical trial of psychedelics to begin as soon as 2021.

Investors have clearly taken note of the ground-floor opportunities taking root in this new space, as Graph Blockchain’s share price has experienced a sharp incline since late January.

(Click image to view website)


Graph Blockchain strongly believes that being one of the first publicly-traded companies in the emerging sector will provide tremendous upside opportunities for their shareholders.


Graph Blockchain’s E-Commerce Platform for Psychedelics

The company says its first endeavour will be to buildout the e-commerce marketplace for the psychedelics industry. The plan is to implement some of GLBC’s key features into its e-commerce platform to ensure a secure and robust program for a regulated and restricted product (psychedelics). The company will look to offer this to industry participants while at the same time use it for its own benefit.

The endgame is to position Graph Blockchain in the psychedelics market as a trusted source for the highest quality products in all legal jurisdictions and be prepared to take advantage of the market when jurisdictions legalize the products. They say the blueprint is the cannabis industry of about seven or eight years ago, where they now see a similar opportunity in psychedelics. Companies such as the aforementioned Compass Pathways, backed by Peter Theil and Warren Buffet, are active in the sector and have been busy actively targeting IPO’s in 2020.


About the Team

Recently appointed CEO, Govinda Butcher, has over 20 years experience in sales, recruitment, personnel development and retention, brand management and business development. He built his first multi-national company, We Move People, which operated in Canada, the U.S, China, and South America. He then became President and CEO of a successful recruitment business. His passion is in building businesses and brands working with dynamic people and creating value for my shareholders.

Mr. Butcher commented on the appointment and his vision for the company moving forward:

“I am excited to take on the role and pivot the company to focus on the huge opportunity that exists in the psychedelics industry. I am very passionate about the industry and see a tremendous opportunity to implement Graph Blockchain’s solutions into an ecommerce platform. My experience building brands and operating across many countries will position graph to expand into all the legal jurisdictions for psychedelics.”

The CEO also says his passion and experience is in building companies and brands and to work with his team to establish relationships with magic truffle producers, magic mushroom growers, and magic mushroom grow kit providers and ancillary products to establish GBLC’s own marketplace.

Graph Blockchain also announced the addition of Matt Humphreys to the team. Mr. Humphreys has nearly 20 years of experience working in the digital space, consulting on a variety of topics including digital transformation, D2C commerce, conversion optimization, user experience and usability. He led the design of Canada’s largest legal recreational Cannabis e-commerce site, Ontario Cannabis Store (https://ocs.ca/). This experience will be directly correlated to the development of Graph’s e-commerce marketplace focused on the psychedelics industry. Mr. Humphreys will be working closely with the company to optimize the website, store design, improving site speed, SEO and conversion optimization.



FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing.


{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today